Evidence map›Paper›PMID 36979584›Full record

ReviewBiosensors2023

Lab on a Chip Device for Diagnostic Evaluation and Management in Chronic Renal Disease: A Change Promoting Approach in the Patients' Follow Up.

Margherita Borriello, Giuseppe Tarabella, Pasquale D'Angelo, Aris Liboà, Mario Barra, Davide Vurro, Patrizia Lombari, Annapaola Coppola, Elvira Mazzella, Alessandra F Perna and 1 more

Open access · goldFull text readReview
In one paragraph

Review in Biosensors, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Aerosol Jet Printing in Biotechnologies.Bioengineering (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Margherita BorrielloDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", via L. De Crecchio, 7, 80138 Naples, Italy.
Giuseppe TarabellaIMEM-CNR, Parco Area delle Scienze 37/A, 43124 Parma, Italy.
Pasquale D'AngeloIMEM-CNR, Parco Area delle Scienze 37/A, 43124 Parma, Italy.ORCID 0000-0002-4500-4457
Aris LiboàIMEM-CNR, Parco Area delle Scienze 37/A, 43124 Parma, Italy.
Mario BarraCNR-SPIN, c/o Dipartimento di Fisica "Ettore Pancini", P.le Tecchio, 80, 80125 Naples, Italy.ORCID 0000-0002-1990-0119
Davide VurroIMEM-CNR, Parco Area delle Scienze 37/A, 43124 Parma, Italy.
Patrizia LombariDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", via L. De Crecchio, 7, 80138 Naples, Italy.
Annapaola CoppolaDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", via L. De Crecchio, 7, 80138 Naples, Italy.
Elvira MazzellaDepartment of Translational Medical Science, University of Campania "Luigi Vanvitelli", via Via Pansini, Bldg 17, 80131 Naples, Italy.
Alessandra F PernaDepartment of Translational Medical Science, University of Campania "Luigi Vanvitelli", via Via Pansini, Bldg 17, 80131 Naples, Italy.ORCID 0000-0003-4048-9392
Diego IngrossoDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", via L. De Crecchio, 7, 80138 Naples, Italy.
University of Campania "Luigi Vanvitelli" · ITInstitute of Materials for Electronics and Magnetism · ITSuperconducting and other Innovative Materials and Devices Institute · IT

Funding

Regione Campania 50CC24C72CA286E9934EF9CC9CD66F14062DE462
6 · The paper itself

Abstract

Lab-on-a-chip (LOC) systems are miniaturized devices aimed to perform one or several analyses, normally carried out in a laboratory setting, on a single chip. LOC systems have a wide application range, including diagnosis and clinical biochemistry. In a clinical setting, LOC systems can be associated with the Point-of-Care Testing (POCT) definition. POCT circumvents several steps in central laboratory testing, including specimen transportation and processing, resulting in a faster turnaround time. Provider access to rapid test results allows for prompt medical decision making, which can lead to improved patient outcomes, operational efficiencies, patient satisfaction, and even cost savings. These features are particularly attractive for healthcare settings dealing with complicated patients, such as those affected by chronic kidney disease (CKD). CKD is a pathological condition characterized by progressive and irreversible structural or functional kidney impairment lasting for more than three months. The disease displays an unavoidable tendency to progress to End Stage Renal Disease (ESRD), thus requiring renal replacement therapy, usually dialysis, and transplant. Cardiovascular disease (CVD) is the major cause of death in CKD, with a cardiovascular risk ten times higher in these patients than the rate observed in healthy subjects. The gradual decline of the kidney leads to the accumulation of uremic solutes, with negative effect on organs, especially on the cardiovascular system. The possibility to monitor CKD patients by using non-invasive and low-cost approaches could give advantages both to the patient outcome and sanitary costs. Despite their numerous advantages, POCT application in CKD management is not very common, even if a number of devices aimed at monitoring the CKD have been demonstrated worldwide at the lab scale by basic studies (low Technology Readiness Level, TRL). The reasons are related to both technological and clinical aspects. In this review, the main technologies for the design of LOCs are reported, as well as the available POCT devices for CKD monitoring, with a special focus on the most recent reliable applications in this field. Moreover, the current challenges in design and applications of LOCs in the clinical setting are briefly discussed.

Indexed as

Cardiovascular DiseasesKidney Failure, ChronicRenal Insufficiency, ChronicFollow-Up StudiesHumansLab-On-A-Chip Devicesbiosensorscardiovascular diseaseCKDLab on a ChipmicrofluidicsPOCTquality control assuranceuremic toxins detection

Identifiers

PMID36979584
PMCPMC10046018
OpenAlexW4324057982

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read1
measurements read9
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.